Nordea Investment Management
AMAG

Nordea Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Nordea Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-38,100
Closed -$703K – 1067
2017
Q3 		$703K Buy
38,100
+900
+2% +$16.8K ﹤0.01% 820
2017
Q2 		$684K Buy
37,200
+400
+1% +$7.93K ﹤0.01% 818
2017
Q1 		$830K Buy
36,800
+7,100
+24% +$170K ﹤0.01% 790
2016
Q4 		$1.03M Buy
+29,700
New +$887K ﹤0.01% 748

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nordea Investment Management's AMAG Position: Q4 2017 in Review

Nordea Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2017, closing a stake of 38,100 shares — an estimated $703K sold.

Nordea Investment Management first reported a position in AMAG in Q4 2016 and held it in 4 quarters. The position peaked at $1.03M in Q4 2016. 170 funds tracked by Wall St. Rank hold AMAG as of Q4 2017.

  • Nordea Investment Management reported no remaining AMAG Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nordea Investment Management sold 38,100 AMAG Pharmaceuticals shares in Q4 2017, an estimated $703K.
  • Nordea Investment Management first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 4 quarters.
  • Nordea Investment Management's AMAG Pharmaceuticals position peaked at $1.03M in Q4 2016.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2017.

Based on Nordea Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.